IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
TLDR
A new web-server tool estimates Ki values from experimentally determined IC50 values for inhibitors of enzymes and of binding reactions between macromolecules and ligands to enable end users to help gauge the quality of the underlying assumptions used in these calculations.Abstract:
A new web-server tool estimates Ki values from experimentally determined IC50 values for inhibitors of enzymes and of binding reactions between macromolecules (e.g. proteins, polynucleic acids) and ligands. This converter was developed to enable end users to help gauge the quality of the underlying assumptions used in these calculations which depend on the type of mechanism of inhibitor action and the concentrations of the interacting molecular species. Additional calculations are performed for nonclassical, tightly bound inhibitors of enzyme-substrate or of macromolecule-ligand systems in which free, rather than total concentrations of the reacting species are required. Required userdefined input values include the total enzyme (or another target molecule) and substrate (or ligand) concentrations, the Km of the enzyme-substrate (or the Kd of the target-ligand) reaction, and the IC50 value. Assumptions and caveats for these calculations are discussed along with examples taken from the literature. The host database for this converter contains kinetic constants and other data for inhibitors of the proteolytic clostridial neurotoxins (http:// botdb.abcc.ncifcrf.gov/toxin/kiConverter.jsp).read more
Citations
More filters
Journal ArticleDOI
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B.
Rita Meleddu,Simona Distinto,Roberto Cirilli,Stefano Alcaro,Matilde Yáñez,Maria Luisa Sanna,Angela Corona,Claudia Melis,Giulia Bianco,Péter Mátyus,Filippo Cottiglia,Elias Maccioni +11 more
TL;DR: The hypothesis that 3,5-diaryl-4, 5-dihydroisoxazoles are promising scaffolds for the design of neuroprotective agents is supported.
Posted ContentDOI
Rational design of a new class of protease inhibitors for the potential treatment of coronavirus diseases
Michael Westberg,Michael Westberg,Yichi Su,Xinzhi Zou,Lin Ning,Brett L. Hurst,Bart Tarbet,Michael Z. Lin +7 more
TL;DR: This work designs new ketoamide-based Mpro inhibitors based on central proline rings and identifies ML1000 as a promising new pre-organized scaffold for the development of anti-coronavirus drugs.
Journal ArticleDOI
One pot InCl3-catalyzed synthesis of 1-glycosylmethyl-1H-imidazoles
Mária Petrušová,Hana Smrtičová,Bozena Pribulova,Silvia Vlčková,Iveta Uhliariková,Tibor Docsa,László Somsák,Ladislav Petruš +7 more
TL;DR: In this paper, a series of 1-glycosylmethyl-4,5-diphenyl-1 H -imidazoles with six different glycosyls were obtained in 48-55% yields from the multicomponent reaction of the corresponding C -gly cosyl methylamines, formaldehyde, benzil, and ammonium acetate under catalysis with indium(III) chloride in methanol at ambient temperature.
Journal ArticleDOI
Functionalized bismuth ferrite harmonic nanoparticles for cancer cells labeling and imaging
Solène Passemard,Davide Staedler,Giona Sonego,Thibaud Magouroux,Guillaume Stéphane Schneiter,Lucienne Juillerat-Jeanneret,Luigi Bonacina,Sandrine Gerber-Lemaire +7 more
TL;DR: A conjugation protocol based on click reaction between alkynyl-containing targeting ligands and poly(ethylene glycol)-coated BFO NPs displaying surface reactive azido groups was developed and demonstrated the ability of these functionalized nanomaterials to act as imaging probes for cancer cells.
Journal ArticleDOI
Compound-protein interaction prediction by deep learning: databases, descriptors and models.
TL;DR: A comprehensive survey of DL-based compound-protein interactions (CPIs) prediction can be found in this article , which summarizes popular databases of small-molecule compounds, proteins and binding complexes.
References
More filters
Journal ArticleDOI
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
TL;DR: The analysis described shows K I does not equal I 50 when competitive inhibition kinetics apply; however, K I is equal to I 50 under conditions of either noncompetitive or uncompetitive kinetics.
Journal ArticleDOI
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization
Zaneta Nikolovska-Coleska,Renxiao Wang,Xueliang Fang,Hongguang Pan,York Tomita,Peng Li,Peter P. Roller,Krzysztof Krajewski,Naoyuki G. Saito,Jeanne A. Stuckey,Shaomeng Wang +10 more
TL;DR: The development of a homogeneous high-throughput assay based on fluorescence polarization for measuring the binding affinities of small-molecule inhibitors to the BIR3 domain of XIAP and results obtained indicated that the FP-based competitive binding assay performs correctly as designed.
Journal ArticleDOI
A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors.
TL;DR: D dose-response measurements generate a linear plot of inhibitor concentration divided by degree of inhibition against velocity without inhibitor divided by velocity with inhibitor, which indicates that the inhibitors of oxidative phosphorylation, rutamycin and bongkrekic acid, are tightly bound to rat liver mitochondria.
Journal ArticleDOI
BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009
TL;DR: The web service via a SOAP (Simple Object Access Protocol) interface for access to the BRENDA data has been further enhanced and a new search option provides the access to protein-specific data.
Journal ArticleDOI
Fluorescence Polarization Competition Assay: The Range of Resolvable Inhibitor Potency Is Limited by the Affinity of the Fluorescent Ligand
TL;DR: The higher the affinity of the fluorescent ligand, the wider the range of inhibitor potency that can be resolved, and an approximate estimate for the low end of inhibitor K(i) values thatCan be resolved is the K(d) value of theorescent ligand.